Sex differences in the pharmacokinetics of anticancer drugs: a systematic review

J Delahousse, AD Wagner, S Borchmann, AA Adjei, J Haanen, F Burgers, A Letsch, A Quaas, S Oertelt-Prigione, BC Özdemir, RHA Verhoeven, O Della Pasqua, A Paci, O Mir · 2024

Read Sex differences in the pharmacokinetics of anticancer drugs: a systematic review by J Delahousse, AD Wagner, S Borchmann, AA Adjei, J Haanen, F Burgers, A Letsch, A Quaas, S Oertelt-Prigione, BC Özdemir, RHA Verhoeven, O Della Pasqua, A Paci, O Mir (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11697095.txt.

Description

A large author team reviews whether men and women handle cancer drugs differently, in a 2024 systematic review. Beyond body weight, sex can change how a drug is absorbed, cleared, and tolerated, which shifts both benefit and side effects. How big and how consistent those gaps are was unclear.

The review covered clinical studies of approved anticancer drugs, excluding hormone-based agents, and counted a sex gap as real when clearance or trough levels differed by at least a fifth. Study quality was scored with a standard federal tool. Knowing which drugs truly behave differently by sex could move dosing from one-size-fits-all toward safer, fairer prescriptions for both men and women.

Catalog record

CREATORJ Delahousse, AD Wagner, S Borchmann, AA Adjei, J Haanen, F Burgers, A Letsch, A Quaas, S Oertelt-Prigione, BC Özdemir, RHA Verhoeven, O Della Pasqua, A Paci, O Mir
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11697095

Browse the full library · About the Tower of Babel